- Home
- HOOK vs AMS Comparison
HOOK vs AMS Comparison
Compare HOOK & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- AMS
- Stock Information
- Founded
- HOOK 2011
- AMS 1980
- Country
- HOOK United States
- AMS United States
- Employees
- HOOK N/A
- AMS N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- HOOK Health Care
- AMS Health Care
- Exchange
- HOOK Nasdaq
- AMS Nasdaq
- Market Cap
- HOOK 18.1M
- AMS 19.3M
- IPO Year
- HOOK 2019
- AMS N/A
- Fundamental
- Price
- HOOK $1.06
- AMS $2.81
- Analyst Decision
- HOOK Buy
- AMS
- Analyst Count
- HOOK 4
- AMS 0
- Target Price
- HOOK $10.67
- AMS N/A
- AVG Volume (30 Days)
- HOOK 48.3K
- AMS 28.6K
- Earning Date
- HOOK 05-08-2025
- AMS 05-13-2025
- Dividend Yield
- HOOK N/A
- AMS N/A
- EPS Growth
- HOOK N/A
- AMS 779.12
- EPS
- HOOK N/A
- AMS 0.61
- Revenue
- HOOK $43,946,000.00
- AMS $24,969,000.00
- Revenue This Year
- HOOK N/A
- AMS $27.74
- Revenue Next Year
- HOOK N/A
- AMS $17.72
- P/E Ratio
- HOOK N/A
- AMS $4.63
- Revenue Growth
- HOOK 118.32
- AMS 20.83
- 52 Week Low
- HOOK $0.98
- AMS $2.64
- 52 Week High
- HOOK $10.50
- AMS $4.60
- Technical
- Relative Strength Index (RSI)
- HOOK 29.63
- AMS 47.68
- Support Level
- HOOK $1.06
- AMS $2.75
- Resistance Level
- HOOK $1.24
- AMS $2.90
- Average True Range (ATR)
- HOOK 0.08
- AMS 0.10
- MACD
- HOOK 0.01
- AMS 0.01
- Stochastic Oscillator
- HOOK 10.34
- AMS 73.08
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.